| INTRODUCTION
Polymorphism is a hallmark of the HLA system, with 15 420 different HLA-A, -B, -C, -DRB1, -DRB3/4/5, -DQA1, -DQB1, -DPA1, -DPB1 alleles reported to date (release 3.26.0, October 2016) to the IPD-IMGT/HLA website. 1, 2 However, according to the catalogue of common and well-documented (CWD) HLA alleles of the American Society for Histocompatibility and Immunogenetics (ASHI), only 1122 (7.3%) of these alleles have been observed several times in unrelated individuals. 3, 4 Since resolution of all possible HLA alleles is increasingly prohibitive for laboratories providing tissue-typing services for transplantation or other clinical purposes, due to the severe cost and time constraints associated with this endeavour, knowledge of the actual occurrences of the reported HLA alleles is of great practical importance. Indeed, current definitions of histocompatibility typing terms consider the possibility of reporting only the CWD alleles. 5 Therefore, the ASHI CWD catalogue has become a major reference for researchers needing to validate their genotyping results or to evaluate the occurrence of specific alleles worldwide for diverse purposes, such as (the articles cited below being examples of studies referring to this catalogue) HLA matching in haematopoietic stem cell transplantation, 6 HLA and disease associations studies 7 and population genetics studies. 8 However,
although the ASHI CWD catalogue comprises as many as 139 961 sequence-based typing (SBT) observations, the vast majority of these (99%) come from the USA (84%) and China (15%). In contrast, the present European landscape is represented by only 252 SBT observations (0.18%) from either The Netherlands (N = 226) and France (N = 26), limiting the applicability of the ASHI CWD catalogue to laboratories serving local populations of very diverse European origins. Currently, no equivalent CWD catalogue exists for Europe itself, although European populations are known to exhibit a high level of HLA diversity and to differ genetically among each other, in particular across several geographical boundaries like mountain ranges and seas. 9, 10 Over the last few years, our knowledge on European HLA diversity has dramatically increased, in particular by typing large hematopoietic stem cell donor registries such as the Deutsche Knochenmarkspenderdatei (DKMS) 11, 12 and by mapping in detail, thanks to the efforts of the HLA-net Consortium (http://hla-net.eu 13 ), the HLA variation across most
European regions including previously under-represented countries like Albania, 14 Croatia, 15 Hungary, 16 Romania, 17 Serbia 18 in South-Eastern Europe and others. 9, 10 Moreover, the web-database allelefrequencies.net (AFND) 19, 20 has collected to date published HLA frequencies from 1066 populations around the world (including Europe), among which 571 with at least one locus typed at 2nd field level of resolution. We may thus expect that the landscape of worldwide CWD alleles might change substantially when including these European data. Within the frame of the European Federation for Immunogenetics (EFI), the Population Genetics Working Group of the Scientific Committee therefore facilitated the establishment of an EFI CWD catalogue in Europe, through a collaborative study using several large HLA databases. The EFI CWD catalogue is presented in this study in comparison to the ASHI compilation, and is expected to be most useful to researchers and clinicians interested in a detailed characterization of European HLA diversity.
| MATERIALS AND METHODS

| Population data
We used 3 large HLA databases to count or estimate the number of CWD alleles in Europe: the GENE[VA] database of the HLA-net platform maintained at the University of Geneva (http://hla-net.eu), the DKMS database of hematopoietic stem cell donors in Germany (https://www.dkms.de/ en) and the allelefrequencies.net database (AFND) maintained at the University of Liverpool (http:// allelefrequencies.net). To include a large number of comparable samples (in this study, the term "sample" is exclusively used to name a set of individuals representative of a given population, and not a single individual), we carried out the study on the 7 most frequently typed loci HLA-A, -B, -C, -DRB1, -DQA1, -DQB1 and -DPB1, that is, we performed the counts on all samples tested for at least one of these 7 loci. Also, we only considered data defined at the 2nd field level of resolution: datasets (ie, the HLA data reported at a given locus for a given population sample; note, indeed, that each population sample may be represented by 1 to 7 datasets depending on the loci for which it was tested, see Table S1 , Supporting information) completely or partially typed at the 1st-field level were not included, and, for datasets defined at a greater resolution level, alleles were recoded to the 2nd field. Finally, we only considered populations of European origin living in Europe (but not necessarily living in their country of origin; note that in this case, we considered their country of origin to classify them into a sub-region as defined below), and, to provide a more detailed distribution of the CWD alleles across Europe, we classified the samples into 5 European sub-regions, namely Central-Western (CW), North-Eastern (NE), Northern (NO), South-Eastern (SE) and SouthWestern (SW) Europe, roughly taking the Pyrenees, the Alps, the Carpathians, the Baltic Sea and the English Channel as boundaries. To avoid duplicated allele counts, we carefully checked that there were no overlapping datasets among those used from the 3 databases (eg, we did not use the DKMS data reported in AFND). The complete list of population samples included in the study (with their regional assignments and sample sizes) is given in Table S1 , and the total number of datasets and individuals are reported in Table 1 . South-Eastern Europe is the bestrepresented sub-region in terms of number of datasets (28 ≤ k ≤ 51), but Central-Western Europe is, by far, the best-represented sub-region in terms of number of individuals (16 684 ≤ N ≤ 3 828 112), meaning that the latter includes very huge population samples (eg, DKMSGerman).
| Definitions of CWD alleles
Following the definition chosen by the EFI Population Genetics Working Group, we reported the alleles as «com-mon» (COM) when more than 3 copies of them were observed in at least 3 different populations, and as «well-documented» (WD) when at least 5 copies of them were found in the total set of populations. The same definitions were used to count the COM or WD alleles within each European sub-region when regional subdivisions were considered. These definitions are equivalent (although a little more precise) to those stated by Mack et al, 4 that is, «have been observed in multiple populations», «ample data supporting their presence and frequency» and «observed at frequencies >.001 in reference populations of at least 1500 individuals», for COM alleles, and «not as widely distributed as the alleles in the Common category», «frequencies are less certain than those of alleles in the Common category» and «observed five times in unrelated individuals through the use of a SBT method that assessed the pertinent exon(s), or if they had been detected three times via SBT and observed in a specific haplotype in unrelated individuals», for WD alleles.
| Allele counting
The number of each COM and WD allele was directly counted by using the genotype distributions for all the population samples available in the GENE [VA] and DKMS databases. By contrast, as AFND includes data in the form of allele frequencies, in this database the absolute number of each allele was estimated by multiplying its frequency by twice the sample size (ie, twice the number of individuals, which is equal, for a given locus, to the number of genes in each population sample). To be conservative, when calculating WD counts over population samples, we only counted an allele when the number of copies was greater than 0.9. We did the computations at all loci taken separately and we also generated total counts for the 7 loci. level of resolution and that we did not take into account the DPA1 and DRB3/4/5 loci, the total number of ASHI CWD alleles used for our comparisons was 1031 instead of the 1122 listed by Mack et al. 4 3 | RESULTS
| Data comparison
| CWD alleles over all of Europe
The complete lists of COM and WD alleles found over all of Europe, and thus included in the present EFI catalogue, are reported in Tables S2 and S3 , respectively, in comparison with those reported in the ASHI catalogue. 4 A schematic representation of the total number of COM and WD alleles found in the two catalogues is given in Figure 1 , for the 7 loci considered together. The detailed data for each locus are represented in a similar way in Figure S1 (S1-A-S1-G). Figure 1 reveals that the total number of CWD alleles is similar in the EFI and ASHI catalogues (1048 vs 1031, respectively). Amongst these, the number of COM alleles is smaller in EFI than in ASHI (236 vs 377), the reverse being observed for WD alleles (812 vs 654). However, only a little more than 200 alleles of each category (216 COM and 212 WD) are shared between the two catalogues. Of the 236 COM alleles reported by EFI, 216 (91.5%) are also reported as COM by ASHI, 12 (5%) are reported as WD by ASHI and the remaining 8 (3.5%) are neither reported as COM nor as WD by ASHI. Interestingly, 5 of the latter 8 alleles were assigned within the last 7 years according to the IPD-IMGT/HLA database 2 ( When combining the EFI and the ASHI catalogues, the total number of CWD alleles amounts to 1544, corresponding to 13.5% of the 11 474 HLA-A, -B, -C, -DRB1, -DQA1, -DQB1 and -DPB1 2nd field alleles reported to date (October 2016) in the IPD-IMGT/HLA website 1, 2 ( Table 3 ). Only 428 of the 1544 CWD alleles (27.7%) are concordantly reported as COM or WD in both catalogues, again underlining important differences between them.
| Inter-locus differences
When we compare in more detail the number of CWD alleles per locus between the two catalogues (Table 4) , we find between 40% and 50% more COM alleles at HLA-A, -B, and -DRB1 loci reported by ASHI compared to EFI , but only about 20%-25% more at HLA-C, -DQA1 and -DPB1, and 5% fewer at -DQB1. In parallel, the ASHI catalogue includes only a small fraction of the WD alleles reported by EFI at HLA-C, -DQA1, -DQB1 and -DPB1, a little fewer (7%-11% less) than EFI at loci -A and -B, and 37% more at locus-DRB1.
| Regional variation
The numbers of COM and WD alleles reported at each locus, both over all of Europe and within each European sub-region, are given in Table 5 provided in Tables S4 and S5 , respectively. At most loci, the number of COM alleles is greater in Central-Western Europe (CW-EUR) but equal or even slightly greater in South-Eastern Europe (SE-EUR) at loci HLA-DQA1 (COM = 8), -DPB1 (COM = 23) and -B (COM = 46, vs 43 in CW-EUR). This may reflect the fact that SE-EUR is represented in the data by more samples than the other subregions (the probability of finding at least 3 samples with more than 3 allele copies increases). Also, the largest amount of WD alleles is observed in CW-EUR (WD = 823), whereas much lower (and close) numbers are found in the other sub-regions (WD = 72 to 114). This is not surprising due to the much larger number of individuals represented in the CW-EUR dataset (the probability of finding at least 5 allele copies in the total number of individuals, independently of the number of samples represented in the region, is higher). Finally, as presented in Table 6 , of the total set of 236 COM alleles reported over all of Europe, only 37 (15.7%) are also COM within all sub-regions. However, an additional set of 41 alleles are COM within all subregions but one, namely 21 alleles within all sub-regions but North-Eastern Europe (NE-EUR), 19 alleles within all sub-regions but South-Western Europe (SW-EUR), and 1 allele within all sub-regions but Northern Europe (NO-EUR). In total, 78 (37 + 41) alleles can thus be considered as widely distributed across Europe. Also, most of the COM alleles observed either over all of Europe or in CW-EUR are WD in one or several other sub-regions, and a total of 91 alleles are either COM or WD in all sub-regions (Table S4 ). In contrast, 25 alleles are only COM within CW-EUR, and 12 alleles are only COM within SE-EUR, suggesting regional variation in the distribution of CWD alleles across the continent, as discussed below.
| DISCUSSION
| The EFI and ASHI catalogues face to face
This study presents the first EFI catalogue (version 1.0) of CWD alleles in Europe, and its comparison to the ASHI catalogue version 2.0.0. 4 The number of population samples (77-121, depending on the HLA locus, for EFI vs 6 for 1 CWD is the total number of CWD alleles in both catalogues combined, that is, the number of alleles that are COM or WD in at least one of the two catalogues. ASHI) and total sample sizes (21 571-3 966 984, depending on the HLA locus, for EFI vs 139 961 for ASHI) vary substantially between the two. Despite the considerably lower number of samples in the ASHI catalogue, the number of COM alleles is higher compared to EFI, possibly reflecting the consideration of population samples with very heterogeneous genetic backgrounds such as United States (US) residents and Brazilians. However, the total number of CWD alleles is surprisingly similar (1048 vs 1031) in both catalogues. Importantly though, only about half of these CWD alleles are shared, while the other half is different. This clearly indicates that one catalogue cannot be used as surrogate for the other, but that both of them should be considered for a most possibly comprehensive picture, and that each catalogue is differently informative in different regions.
It should be noted that the findings from CWD compilations are influenced by a number of features other than the genetic background of the individuals analysed. These include sample size and number, HLA typing methods and regional practices of reporting, as well as time-dependent changes in the knowledge of reported and hence analysed alleles. The latter issues are likely to become less relevant with increasing use of next generation sequencing (NGS) for HLA typing purposes, which has dramatically reduced (but not completely eliminated) the occurrence of typing ambiguities, and allows for the detection of new, previously unknown polymorphisms within the amplified region. [21] [22] [23] It is thus to be expected that the number of CWD alleles will rapidly increase in the near future, calling for regular updates of the EFI and ASHI catalogues. Regional practices for HLA reporting may also influence the observation of CWD alleles. For instance, 2 of the 8 CWD alleles in the EFI catalogue not reported in ASHI belong to G-groups (ie, groups of alleles that have identical nucleotide sequences across the exons encoding the peptide binding domains, http://hla.alleles.org/alleles/g_groups.html) and therefore might not be reported according to local regulations. This applies to DPB1*124:01 which is part of DPB1*03:01G, and DPB1*126:01 part of DPB1*04:01G. Regarding sampling parameters, sample size affects the probability of detecting non-frequent alleles present in a population: low sample sizes may mostly lead to underestimation of COM alleles, because each COM allele is supposed to occur more than 3 times in at least 3 population samples. By contrast, WD alleles are defined by counting them at least 5 times in the total set of population samples, so many small samples may be equivalent, from a statistical Many alleles are still to be discovered, among which new alleles generated by different molecular mechanisms. 
| A snapshot of HLA typing history
Another interesting observation of the present study is that different HLA loci exhibit very different numbers of COM and WD alleles. Actually, the results seem to reflect the state of the art in terms of HLA typing. Indeed, one explanation may be that molecular typing of the HLA-C, -DQA1, -DQB1 and -DPB1 loci improved particularly in recent years, leading to an increase of the repertoire of COM and WD alleles at these loci in the present EFI catalogue, built at least 3 years after the ASHI catalogue. On the other hand, the HLA-A, -B and -DRB1 loci have been typed since much longer in the field of transplantation (and locus DRB1 also since a very long time by molecular techniques), explaining why new COM and WD alleles will more rarely be found at these loci nowadays. New updates of the ASHI catalogue are thus expected to increase more significantly the number of CWD alleles at the 4 loci HLA-C, -DQA1, -DQB1 and -DPB1, compared to the other 3 loci.
| Regional variation of the CWD European catalogue
In this study, we have listed 37 alleles, among the 236 which are common all over of Europe, as being COM also within each of the 5 European sub-regions considered. In addition, 41 alleles are also COM within all sub-regions but one, the latter being either (except for 1 allele) NE-EUR (Russia, Moldavia, Belarus and Ukraine) or SW-EUR (Spain, mainland Portugal, Azores and Madeira) extending towards North-East Asia and North-West Africa, respectively. Actually, these two sub-regions are poorly represented in terms of number of samples, which may be a reason for some alleles to appear more rarely than in the rest of Europe. Taking this potential sampling bias into account, we can reasonably consider that a total of 78 (37 + 41) alleles are widely distributed in Europe. On the other hand, the great majority of COM alleles defined in this continent (ie, the remaining 158) appears to be unevenly distributed from one sub-region to the other. We confirmed through an analysis of variance that this heterogeneous distribution was due in part to the very imbalanced numbers of samples and individuals represented in the different sub-regions (Table S6) . Interestingly, however, this analysis also shows that the classification of population samples into the 5 sub-regions defined in our study contributes to explain the observed numbers of COM and WD alleles, as the result remains significant after taking into account the effects of the number of samples and individuals, therefore indicating that CWD counts behave differently across different European sub-regions. Anotherthis time qualitative-observation supports this conclusion. Indeed, whereas 25 alleles are only COM within CW-EUR, as many as 12 alleles are COM only within SE-EUR, showing that a substantial number of COM alleles are different between the two best-represented regions. Altogether, these results suggest that the distribution of CWD alleles is not uniform in this continent, as already stressed in some specific studies. 15, 28 This conclusion is in agreement with the recently published HLA map of Europe which showed heterogeneity of allele and haplotype frequencies across its different sub-regions. 9, 10 In particular, the peculiar pattern of CWD alleles here reported for SE-EUR supports previous observations that this sub-region is particularly diverse for HLA (with populations showing a high heterozygosity), probably due to its geographic continuity-and hence more gene flow-with the Near-East. 9, 10 Let us keep in mind, however, that CWD counts, like those reported in the present study, only describe a small part of the regional HLA variation existing in Europe, because many of the alleles found to be common in all (or all but one) European subregions also exhibit substantial frequency variation across the continent, a result that can only be stressed by analysing in detail full HLA allelic distributions within and between populations. Both approaches are thus complementary from a population genetics point of view.
| Towards a global perspective
The outstanding group of 78 alleles mentioned above suggests that some alleles are common everywhere while others might be limited to some area and are not COM or WD in a larger scope. One way to account for such a situation is the consideration of a new category, to be designated global alleles, which are common almost everywhere. However, the key point is that CWD catalogues will have to address the questions of how many population samples are used in their compilation and what is their geographical dispersion. Such an approach will require more categories combining the observed number of copies, the number of samples presenting these copies and their geographical repartition. For instance, a global («GLO») allele would have to be present in most population samples in more than 3 copies, and a regional («REG») allele would verify the same condition for a region.
| SUMMARY AND OUTLOOK
The results from this study demonstrate that only 13.5% of the impressive polymorphism reported in HLA is actually found in more than isolated samples around the world. While this number is not cut in stone with increasing highthroughput ultra-high resolution HLA typing techniques, the observation raises important practical and scientific considerations. From a practical point of view, the EFI catalogue of CWD alleles presented here will be of utmost utility to tissue-typing laboratories serving communities of predominantly European descent. Sweeping migration of various ethnicities is rapidly increasing globalization, rendering international endeavours towards worldwide catalogues an urgently warranted necessity. The availability of the combined data from the EFI and ASHI CWD catalogues presented in this study will be helpful for streamlining efforts, resources and eventually time needed for HLA reporting, all of which is in the best interest of patients. From a scientific point of view, the observation of a huge amount of very rare HLA variants, even at the level of Europe alone, raises stimulating questions regarding the underlying biological function and the evolutionary forces driving this polymorphism. Clearly, the increasing level of HLA diversity detected in populations still needs to be analysed in detail and compared to neutral variation across the whole genome to understand better the mechanisms of its molecular evolution.
